Pharma Journalist 8962 posts 0 comments

Bristol-Myers Squibb Company and Compugen announced the companies have entered into a clinical trial collaboration to evaluate the safety and tolerability of Compugen’s COM701, an…
Read More...

The first clinical trial of a completely novel and unprecedented approach to modifying the progression of Alzheimer's disease has opened in London. The study is being conducted in the…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) seeking…
Read More...

Allergan has joined the TriNetX global health research network for real-time access to patient populations, driven and refreshed by clinical data, to determine protocol feasibility,…
Read More...

ROSLINCT announced it is to receive investment to collaborate with REPROCELL Europe Ltd (REPROCELL), a UK-based stem cell company, on a £1.2 million project which will develop a faster,…
Read More...

The Mundipharma global network of independent associated companies has added development capabilities to its biosimilars platform with the purchase of biosimilars development company…
Read More...

Ionis Pharmaceuticals announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases. This collaboration will leverage Ionis'…
Read More...

Marina Biotech announced that it has changed its name to Adhera Therapeutics and that it will begin using the ticker ATRX, in each case effective October 9, 2018. This new name reflects…
Read More...

Recipharm has released its first serialised products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden. In 2016 Recipharm committed to invest 40 million euros…
Read More...

USP is announcing a new program to assist manufacturers in their drug development efforts—Impurities for Development (IfD). This new program can help pharmaceutical manufacturers meet…
Read More...